Atopy and allergy following solid organ transplantation: A 15-year experience.
allergy
gastroenterology
nephrology/renal
Journal
Journal of paediatrics and child health
ISSN: 1440-1754
Titre abrégé: J Paediatr Child Health
Pays: Australia
ID NLM: 9005421
Informations de publication
Date de publication:
03 2023
03 2023
Historique:
revised:
08
10
2022
received:
03
09
2022
accepted:
20
01
2023
medline:
30
3
2023
pubmed:
31
1
2023
entrez:
30
1
2023
Statut:
ppublish
Résumé
There are increasing reports of atopy/allergy following solid organ transplantation, especially paediatric liver transplantation (LT) with minimal New Zealand (NZ) data. We describe the prevalence of transplant-acquired atopy and allergy (TAA) in NZ paediatric liver transplant recipients, compared to paediatric kidney and adult liver transplants. TAA focussed health questionnaires were sent to patients selected from the NZ transplant registry (transplanted between January 2003 and December 2017). Demographic and clinical data were also obtained from electronic health records and follow-up phone calls. A total of 232 patients (62% male) participated (111 adult liver, 82 paediatric liver, 39 paediatric kidney transplant recipients). Tacrolimus was primary immunosuppression for all LT patients; with combined tacrolimus, mycophenolate and corticosteroids for kidney transplants. The number of patients who developed TAA was significantly higher (P < 0.001) in the paediatric LT group (36/82, 44%) compared to adult liver (12/111, 11%) and paediatric kidney transplants (4/39, 10%). Eczema was most common (73%), then IgE-mediated food allergy (FA, 33%), allergic rhinitis (19%) and asthma (17%). Six paediatric LT recipients developed eosinophilic oesophagitis (EoE). Egg was the most common allergen in the IgE-mediated FA group. TAAs were severe enough to warrant a switch from tacrolimus to another agent in seven paediatric LT patients. For paediatric LT patients, female gender and younger age at transplant were risk factors for developing TAA. TAA is common in paediatric liver transplant recipients, with female gender and younger age at transplant being risk factors identified. This highlights the need for detailed atopic and allergy history to be incorporated in all pre-transplant assessments.
Substances chimiques
Tacrolimus
WM0HAQ4WNM
Immunoglobulin E
37341-29-0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
537-541Subventions
Organisme : Auckland District Health Board
Informations de copyright
© 2023 The Authors. Journal of Paediatrics and Child Health published by John Wiley & Sons Australia, Ltd on behalf of Paediatrics and Child Health Division (The Royal Australasian College of Physicians).
Références
Stormon MO, Hardikar W, Evans HM, Hodgkinson P. Paediatric liver transplantation in Australia and New Zealand: 1985-2018. J. Paediatr. Child Health 2020; 56: 1739-46.
Miserachs M, Nicholas DB, Otley AR, Ng VL. Health-related quality of life after pediatric liver transplantation: A qualitative analysis of the perspectives of health care providers. Can. J. Gastroenterol. Hepatol. 2017; 2017: 5274923.
Ng VL, Fecteau A, Shepherd R et al. Outcomes of 5-year survivors of pediatric liver transplantation: Report on 461 children from a north american multicenter registry. Pediatrics 2008; 122: e1128-35.
Sheikh A, Cundy T, Evans HM. Growth, body composition, and bone density following pediatric liver transplantation. Pediatr. Transplant. 2018; 22: e13201.
Heisel O, Heisel R, Balshaw R, Keown P. New onset diabetes mellitus in patients receiving calcineurin inhibitors: A systematic review and meta-analysis. Am. J. Transplant. 2004; 4: 583-95.
Nobili V, de Ville de Goyet J. Pediatric post-transplant metabolic syndrome: New clouds on the horizon. Pediatr. Transplant. 2013; 17: 216-23.
Spencer CM, Goa KL, Gillis JC. Tacrolimus. An update of its pharmacology and clinical efficacy in the management of organ transplantation. Drugs 1997; 54: 925-75.
Evans HM. The increasing burden of atopy and allergy after solid organ transplantation in children. J. Pediatr. 2018; 196: 10-1.
Marcus N, Amir AZ, Grunebaum E et al. De novo allergy and immune-mediated disorders following solid-organ transplantation-Prevalence, natural history, and risk factors. J. Pediatr. 2018; 196: 154-60 e2.
Noble C, Peake J, Lewindon P. Increase in de novo allergies after paediatric liver transplantation: The Brisbane experience. Pediatr. Transplant. 2011; 15: 451-4.
Levy Y, Davidovits M, Cleper R, Shapiro R. New-onset post-transplantation food allergy in children - Is it attributable only to the immunosuppressive protocol? Pediatr. Transplant. 2009; 13: 63-9.
Özdemir Ö. New developments in transplant-acquired allergies. World J. Transplant. 2013; 3: 30-5.
Brown C, Haringman N, Davies C et al. High prevalence of food sensitisation in young children with liver disease: A clue to food allergy pathogenesis? Pediatr. Allergy Immunol. 2012; 23: 770-7.
Gabe SM, Bjarnason I, Tolou-Ghamari Z et al. The effect of tacrolimus (FK506) on intestinal barrier function and cellular energy production in humans. Gastroenterology 1998; 115: 67-74.
Vagefi PA, Blazick E, Hamilos D, Ades A, Cosimi AB, Hertl M. Transference of food allergy after adult liver transplantation. Transplantation 2009; 87: 1426.
Brunetta DM, Albuquerque LM, Batista AHM et al. Passenger lymphocyte syndrome in liver transplantation. Rev. Bras. Hematol. Hemoter. 2017; 39: 364-7.
Richter N, Raddatz G, Steinhoff G, Schäfers HJ, Schlitt HJ. Transmission of donor lymphocytes in clinical lung transplantation. Transpl. Int. 1994; 7: 414-9.
Asher M, Barry D, Clayton T et al. The burden of symptoms of asthma, allergic rhinoconjunctivitis and atopic eczema in children and adolescents in six New Zealand centres: ISAAC Phase One. N. Z. Med. J. 2001; 114: 114-20.
Stevens PE, Levin A; Kidney Disease: Improving Global Outcomes Chronic Kidney Disease Guideline Development Work Group Members. Evaluation and management of chronic kidney disease: Synopsis of the kidney disease: Improving global outcomes 2012 clinical practice guideline. Ann. Intern. Med. 2013; 158: 825-30.
Barış Z, Köksal B, Özbek Ö, Özçay F, Haberal M. Incidence, clinical features, and outcomes of food allergy in children who underwent liver transplant: 16-year experience. Pediatr. Transplant. 2019; 23: e13399.
Shroff P, Mehta RS, Chinen J, Karpen SJ, Davis CM. Presentation of atopic disease in a large cohort of pediatric liver transplant recipients. Pediatr. Transplant. 2012; 16: 379-84.
Phan TG, Strasser SI, Koorey D et al. Passive transfer of nut allergy after liver transplantation. Arch. Intern. Med. 2003; 163: 237-9.
Evans HM, Asher MI, Cameron-Christie S et al. Ethnic disparity in the incidence and outcome of biliary atresia in New Zealand. J. Pediatr. Gastroenterol. Nutr. 2018; 66: 218-21.
De Bruyne R, Dullaers M, Van Biervliet S et al. Post-transplant food allergy in children is associated with liver and not with renal transplantation: A monocentric comparative study. Eur. J. Pediatr. 2013; 172: 1069-75.